InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (12 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
12
T+90 hit rate
67%
T+90 mean return
+5.2%
Across 15 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by WAGNER CHARLES F JR, Chief Financial Officer. Director active across 1 company, notably Vertex Pharmaceuticals INC / MA. Cumulatively, 34 filings have been logged. Breakdown: 0 buy · 12 sells. Total volume traded: €9.2m. History available since 30 April 2021. The latest transaction was disclosed on 10 March 2025 (Cession). Regulator: SEC (Form 4). All data is openly available.
Declarations34 total
▼
3,298 shares@ US$500.006.4% of flowCommon StockSEC:0000875320-25-000148:0
●
4,962 shares@ US$479.619.5% of flowCommon StockSEC:0000875320-25-000137:0
●
3,310 shares@ US$483.286.4% of flowCommon StockSEC:0000875320-25-000117:0
●
2,293 shares@ US$463.464.3% of flowCommon StockSEC:0000875320-25-000097:0
6,655 shares0Common StockSEC:0000875320-25-000075:0
●
2,649 shares@ US$467.985.1% of flowCommon StockSEC:0000875320-25-000050:0
10,262 shares0Common StockSEC:0000875320-25-000026:0
▼
3,000 shares@ US$518.276.1% of flowCommon StockSEC:0000875320-24-000227:0
▼
3,250 shares@ US$460.005.8% of flowCommon StockSEC:0000875320-24-000170:0
▼
3,250 shares@ US$454.795.7% of flowCommon StockSEC:0000875320-24-000162:0
●
3,309 shares@ US$431.795.6% of flowCommon StockSEC:0000875320-24-000111:0
●
3,750 shares@ US$424.016.2% of flowCommon StockSEC:0000875320-24-000082:0
●
2,607 shares@ US$422.744.3% of flowCommon StockSEC:0000875320-24-000057:0
5,814 shares0Common StockSEC:0000875320-24-000034:0
▼
3,000 shares@ US$405.004.6% of flowCommon StockSEC:0000875320-24-000002:0
▼
3,000 shares@ US$349.884.1% of flowCommon StockSEC:0000875320-23-000043:0
▼
1,768 shares@ US$305.382.1% of flowCommon StockSEC:0001209191-23-021394:0
▼
360 shares@ US$294.520.4% of flowCommon StockSEC:0001209191-23-020244:0
▼
361 shares@ US$286.640.4% of flowCommon StockSEC:0001209191-23-018460:0
●
3,308 shares@ US$289.123.8% of flowCommon StockSEC:0001209191-23-013774:0
●
3,750 shares@ US$292.854.3% of flowCommon StockSEC:0001209191-23-011707:0
●
2,707 shares@ US$294.333.1% of flowCommon StockSEC:0001209191-23-009243:0
10,324 shares0Common StockSEC:0001209191-23-007012:0
▼
20 shares@ US$254.870.0000% mcap0.2% of flowCommon StockSEC:0000899243-22-016635:0
●
547 shares@ US$276.170.0001% mcap5.2% of flowCommon StockSEC:0000899243-22-016318:0
25 of 34 declarations
About WAGNER CHARLES F JR
Charles F. Wagner Jr is Executive Vice President and Chief Financial Officer at Vertex Pharmaceuticals Inc. He oversees the financial operations of the company, ensuring effective resource management and contributing to financial strategy. His role is essential for the financial health of the organization.
